Form 8-K - Current report:
SEC Accession No. 0001493152-24-043518
Filing Date
2024-11-04
Accepted
2024-11-04 16:30:16
Documents
18
Period of Report
2024-10-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46509
2 ex10-1.htm EX-10.1 19990
3 ex10-2.htm EX-10.2 20256
4 ex10-3.htm EX-10.3 19974
5 ex10-4.htm EX-10.4 19812
6 ex10-5.htm EX-10.5 20419
  Complete submission text file 0001493152-24-043518.txt   335480

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE arth-20241029.xsd EX-101.SCH 3039
8 XBRL LABEL FILE arth-20241029_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE arth-20241029_pre.xml EX-101.PRE 24181
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3354
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

EIN.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 241424058
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)